Provided by Tiger Trade Technology Pte. Ltd.

LivaNova PLC

76.39
+0.48000.63%
Post-market: 76.390.00000.00%16:38 EDT
Volume:339.43K
Turnover:25.95M
Market Cap:4.20B
PE:22.53
High:77.66
Open:76.12
Low:75.63
Close:75.91
52wk High:85.76
52wk Low:48.82
Shares:54.93M
Float Shares:54.68M
Volume Ratio:0.64
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.39
EPS(LYR):-4.4500
ROE:15.40%
ROA:5.04%
PB:3.17
PE(LYR):-17.17

Loading ...

LivaNova Price Target Announced at $105.00/Share by Barclays

Dow Jones
·
Oct 07

LivaNova initiated with an Overweight at Barclays

TIPRANKS
·
Oct 07

LivaNova (LIVN) Looks Mispriced Following A Pullback In A Stronger Long Term Story

Simply Wall St.
·
Sep 25

LivaNova to Discuss Third-Quarter 2026 Results on Conference Call

Reuters
·
Sep 23

LivaNova to Announce Third-Quarter 2026 Results

THOMSON REUTERS
·
Sep 23

LivaNova Director Francesco Bianchi Sells 3,500 Shares for $273,032.20

Reuters
·
Sep 15

LivaNova Director Brooke Story Sells 2,300 Shares for $187,270.14

Reuters
·
Sep 09

LivaNova Presents at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 03

LivaNova Files Form 3 for Chief Legal Officer Anne M. Liddy

Reuters
·
Sep 03

LivaNova Director Francesco Bianchi Sells 1,650 Shares for $131,538

Reuters
·
Sep 03

LivaNova Price Target Raised to $90.00/Share from $87.00 by Piper Sandler

Dow Jones
·
Sep 03

LivaNova price target raised to $90 from $87 at Piper Sandler

TIPRANKS
·
Sep 02

LivaNova Chief Innovation Officer Ahmet Tezel Disposes of Shares Worth $435,409.36

Reuters
·
Aug 14

iRhythm Q2 Revenue Beats Estimates on Sustained Volume Demand, Lifts FY Guidance

Reuters
·
Aug 07

Pulse Biosciences Q2 Net Loss Widens, Cash Position Strengthens

Reuters
·
Aug 07

LivaNova PLC Lifts Guidance on Record Q2 Results

TIPRANKS
·
Aug 06

Nyxoah Q2 Revenue Surges on U.S. Growth, but Margins Drop

Reuters
·
Aug 06

LivaNova is Maintained at Buy by Needham

Dow Jones
·
Aug 06

LivaNova PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05